The eye care supplement market is projected to be worth US$ 2,457.5 million in 2024. The market is likely to reach US$ 4,613.0 million by 2034. The market is further expected to surge at a CAGR of 6.5% during the forecast period 2024 to 2034.
| Attributes | Key Insights |
|---|---|
| Eye Care Supplement Market Estimated Size in 2024 | US$ 2,457.5 million |
| Projected Market Value in 2034 | US$ 4,613.0 million |
| Value-based CAGR from 2024 to 2034 | 6.5% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The scope for eye care supplement rose at a 6.0% CAGR between 2019 and 2023. The global market for eye care supplement is anticipated to grow at a moderate CAGR of 6.5% over the forecast period 2024 to 2034.
| Report Attributes | Details |
|---|---|
| Market Value in 2019 | US$ 1,809.9 million |
| Market Value in 2023 | US$ 2,301.8 million |
| CAGR from 2019 to 2023 | 6.0% |
The eye care supplement market experienced a significant growth during the historical period from 2019 to 2023. The aging global population was likely a significant driver, leading to a rise in age related eye conditions and an increased demand for eye care supplements. Rising awareness of the importance of preventive health measures and the role of nutrition in maintaining eye health likely contributed to the growth of the eye care supplement market.
The proliferation of digital devices and concerns about the impact of blue light on eye health may have driven the development and adoption of supplements targeting digital eye strain. Ongoing research and innovation in supplement formulations, including the use of scientifically proven ingredients, likely played a role in market growth.
The forecast period from 2024 to 2034 is expected to witness accelerated growth in the market. Continued advancements in supplement delivery systems and technology are expected to enhance the bioavailability and effectiveness of eye care supplements. The trend of personalized nutrition, possibly guided by genetic testing, may lead to the development of highly customized eye care supplement regimens.
Increased integration of digital tools, such as mobile apps for tracking eye health and supplement adherence, may enhance consumer engagement and contribute to market growth. The eye care supplement market may see increased expansion into emerging markets as healthcare awareness grows in those regions.
Clearer regulations and support for health claims related to eye health can enhance consumer trust and confidence, driving market growth. The adoption of holistic health approaches may lead to the development of supplements that address both eye health and overall well being. A growing understanding of the link between mental health and eye health can lead to the development of supplements targeting stress related eye issues.
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by the United States and China. The countries are expected to lead the market through 2034.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 7.0% |
| Germany | 5.5% |
| The United Kingdom | 5.6% |
| China | 6.4% |
| India | 6.0% |
The eye care supplement market in the United States expected to expand at a CAGR of 7.0% through 2034. Growing awareness among the population of the United States about the importance of eye health and preventive measures has led to an increased interest in eye care supplements.
The broader trend toward preventive healthcare has influenced consumers to take proactive steps to maintain eye health, contributing to the demand for eye care supplements. Concerns about digital eye strain have risen, with the widespread use of digital devices in the United States. Eye care supplements addressing the effects of prolonged screen time have gained popularity.
The eye care supplement market in India is anticipated to expand at a CAGR of 6.0% through 2034. India is experiencing demographic changes, with an aging population. There is an increased risk of age related eye conditions, as individuals age in the country, which is expected to create a demand for supplements supporting eye health.
The expanding middle class population in India, coupled with increasing disposable income, provides consumers with the financial capacity to invest in health and wellness products, including eye care supplements.
The eye care supplement market in Germany is poised to expand at a CAGR of 5.5% through 2034. Government led health initiatives promoting preventive healthcare and wellness are expected to contribute to increased awareness and acceptance of eye care supplements in Germany.
Germany has stringent regulations for dietary supplements, providing consumers with confidence in the safety and quality of products. Regulatory support can positively influence market growth. The country has a culture that values an active lifestyle and fitness. The trend is likely to lead to the demand for supplements that support overall well being, including eye health.
Eye care supplement trends in China are taking a turn for the better. A 6.4% CAGR is forecast for the country from 2024 to 2034. Rapid urbanization and changing lifestyles in China have led to dietary shifts and increased reliance on processed foods. There is a growing interest in supplements to fill nutritional gaps.
The prevalence of e-commerce platforms in China facilitates easy access to a wide range of dietary supplements, making it convenient for consumers to purchase eye care supplements online. Traditional Chinese medicine places importance on holistic approaches to health. The cultural emphasis may contribute to the acceptance of supplements, including those for eye health.
The eye care supplement market in the United Kingdom is anticipated to expand at a CAGR of 5.6% through 2034. Collaborations between supplement manufacturers and healthcare professionals, such as ophthalmologists or optometrists, can enhance consumer trust and confidence in eye care supplements.
Deficiencies in essential vitamins and minerals, such as vitamin A, vitamin C, vitamin E, zinc, and omega-3 fatty acids, can impact eye health. Supplements addressing these deficiencies may see increased demand.
Growing consumer preference for natural and plant-based ingredients in supplements is expected to lead to the development of eye care supplements with botanical extracts and natural compounds known for their eye health benefits.
The below table highlights how lutein and zeaxanthin segment is projected to lead the market in terms of ingredients, and is expected to account for a share of 37.0% in 2024.
Based on dosage form, the tablet segment is expected to account for a share of 21.5% in 2024.
| Category | Shares in 2024 |
|---|---|
| Lutein and Zeaxanthin | 37.0% |
| Tablet | 21.5% |
Based on ingredients, the lutein and zeaxanthin segment is expected to continue dominating the eye care supplement market. The segment is expected to account for a share of 37.0% in 2024.
Lutein and zeaxanthin are carotenoids with strong antioxidant properties. Antioxidants help protect the eyes from oxidative stress caused by free radicals, contributing to overall eye health.
Lutein and zeaxanthin are particularly beneficial for maintaining macular health. The macula is a part of the retina responsible for central vision, and these carotenoids are known to accumulate in the macula, helping protect against age related macular degeneration.
Some studies suggest that higher dietary intake or supplementation of lutein and zeaxanthin may be associated with a reduced risk of developing cataracts, a common age related eye condition.
Lutein and zeaxanthin act as natural filters that protect the eyes from phototoxic damage caused by exposure to ultraviolet light. The protective effect contributes to overall eye health.
In terms of dosage form, the tablet segment is expected to continue dominating the eye care supplement market. The segment is expected to account for a share of 21.5% in 2024.
Tablets are a convenient and portable dosage form, making them easy for consumers to incorporate into their daily routines. The ease of storage and consumption contributes to the popularity of tablets as a preferred dosage form.
Tablets offer precise dosage control, ensuring that consumers receive consistent amounts of active ingredients, which is particularly important for eye care supplements where accurate dosing is essential for optimal results.
Tablets generally have a longer shelf life compared to some other dosage forms, providing stability for eye care supplements and reducing the likelihood of product degradation over time.
The manufacturing process for tablets is well established and standardized, allowing for efficient production and stringent quality control, which contributes to the reliability and consistency of tablet formulations.
The key strategies chosen by large companies include several growth strategies such as technology development, expansion as well and mergers and acquisitions to surge market share, reach and revenue.
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 2,457.5 million |
| Projected Market Valuation in 2034 | US$ 4,613.0 million |
| Value-based CAGR 2024 to 2034 | 6.5% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ million |
| Key Regions Covered | North America Latin America Western Europe Eastern Europe South Asia and Pacific East Asia The Middle East & Africa |
| Key Market Segments Covered | Ingredients Dosage Form Route of Administration Indication Distribution Channel Region |
| Key Countries Profiled | The United States Canada Brazil Mexico Germany France France Spain Italy Russia Poland Czech Republic Romania India Bangladesh Australia New Zealand China Japan South Korea GCC countries South Africa Israel |
| Key Companies Profiled |
|
The market is expected to reach US$ 2,457.5 million in 2024.
The market is set to expand by a CAGR of 6.5% by 2034.
The market is forecast to reach US$ 4,613.0 million by 2034.
The United States is to be the top performing market, with a CAGR of 7.0% through 2034.
Lutein and Zeaxanthin segment is preferred, and is expected to account for a share of 37.0% in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Brand Mapping Analysis 3.1. Price v/s Product 3.2. Value for Money 3.3. Top-of-Mind Brands 3.4. Brand Portfolio-by Key Players 3.5. Brand Loyalty Mapping 3.6. Usage Pattern Overview 3.7. Branded vs Unbranded-Market Mix 4. Distribution Channel Wise Key Brand Positioning 4.1. Global Top Retailers and their Brand Offerings 4.1.1. Retail Pharmacy (Key Brands) 4.1.2. Hospital Pharmacy (Key Brands) 4.1.3. Diagnostic Centers (Key Brands) 4.1.4. Online Sales (Key Brands) 4.2. Retail Pricing Strategies 5. Consumer Buying Behavior Analysis 5.1. Functionality and Product Demand 5.1.1. Lutein and Zeaxanthin 5.1.2. Antioxidants 5.1.3. Omega-3 Fatty Acids 5.1.4. Coenzyme Q10 5.1.5. Flavonoids 5.1.6. Astaxanthin 5.1.7. Alpha-Lipoic Acid 5.1.8. Others 5.2. What factors do you consider when deciding to purchase Eye Care Supplements? 5.3. How important are product certifications when choosing Eye Care Supplements? 5.4. How important is the brand reputation and recognition when selecting Eye Care Supplements? 5.5. What marketing channels do you prefer for learning about new hair Eye Care Supplements? 5.6. How often do you purchase new hair Eye Care Supplements? 5.6.1. Once or More Every Month 5.6.2. Once Every 2 months 5.6.3. Once Every 6 Months 5.6.4. Once a Year 5.6.5. Less Than Once A Year 6. Market Trends & Dynamics 6.1. Per capita spending 6.2. Key Trends Impacting the Market 6.3. Product Innovation / Development Trends 6.3.1. Latest Trends and Demands 6.3.2. Latest Innovations and New Launches 6.4. Future Prospects of the Industry 6.5. Market Dynamics 6.5.1. Drivers 6.5.2. Restraints 6.6. Opportunity Analysis 7. Key Success Factors 7.1. New Product Launches 7.2. Technology Roadmap 7.3. PESTEL Analysis 7.4. Porter’s Analysis 7.5. Product Features/ USPs 7.6. Key Promotional Strategies, By Key Manufacturers 7.7. Regulatory Landscape 8. Market Background 8.1. Macro-Economic Factors 8.1.1. Global GDP Growth Outlook 8.1.2. Global Healthcare Expenditure 8.1.3. Global Ophthalmic Drugs Market Outlook 8.2. Forecast Factors - Relevance & Impact 8.2.1. Key Player’s Historic Growth 8.2.2. Market Consolidation Activities 8.2.3. Formation 8.2.4. Growing Preference 8.2.5. Rising Cases of Macular Degeneration and Refractive Errors 8.3. Market Dynamics 8.3.1. Drivers 8.3.2. Restraints 8.3.3. Opportunity Analysis 9. Global Market Demand Value or Size (in US$ Million) Analysis 2019 to 2023 and Forecast, 2024 to 2034 9.1. Historical Market Value (US$ Million) Analysis, 2019 to 2023 9.2. Current and Future Market Value (US$ Million) Projections, 2024 to 2034 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Ingredients 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Ingredients, 2019 to 2023 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Ingredients, 2024 to 2034 10.3.1. Lutein and Zeaxanthin 10.3.2. Antioxidants 10.3.3. Omega-3 Fatty Acids 10.3.4. Coenzyme Q10 10.3.5. Flavonoids 10.3.6. Astaxanthin 10.3.7. Alpha-Lipoic Acid 10.3.8. Others 10.4. Market Attractiveness Analysis By Ingredients 11. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Dosage Form 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) By Dosage Form, 2019 to 2023 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Dosage Form, 2024 to 2034 11.3.1. Tablet 11.3.2. Capsules 11.3.3. Gels 11.3.4. Liquid 11.3.5. Gummies 11.4. Market Attractiveness Analysis By Dosage Form 12. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Million) Analysis By Route of Administration, 2019 to 2023 12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Route of Administration, 2024 to 2034 12.3.1. Oral 12.3.2. Topical 12.3.3. Parentral 12.4. Market Attractiveness Analysis By Route of Administration 13. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication 13.4. Introduction / Key Findings 13.5. Historical Market Size (US$ Million) Analysis By Indication, 2019 to 2023 13.6. Current and Future Market Size (US$ Million) Analysis and Forecast By Indication, 2024 to 2034 13.6.1. Age-related Macular Degeneration (AMD) 13.6.2. Cataract 13.6.3. Dry Eye Syndrome 13.6.4. Glaucoma 13.6.5. Others 13.7. Market Attractiveness Analysis By Indication 14. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 14.4. Introduction / Key Findings 14.5. Historical Market Size (US$ Million) By Distribution Channel, 2019 to 2023 14.6. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034 14.6.1. Retail Pharmacies 14.6.2. Hospital Pharmacies 14.6.3. Online Pharmacies 14.6.4. Opthalmic Stores 14.7. Market Attractiveness Analysis By Distribution Channel 15. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 15.4. Introduction 15.5. Historical Market Size (US$ Million) Analysis by Region, 2019 to 2023 15.6. Current Market Size (US$ Million) Analysis and Forecast by Region, 2024 to 2034 15.6.1. North America 15.6.2. Latin America 15.6.3. Europe 15.6.4. East Asia 15.6.5. South Asia 15.6.6. Oceania 15.6.7. Middle East and Africa (MEA) 15.7. Market Attractiveness Analysis By Region 16. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16.4. Introduction 16.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023 16.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034 16.6.1. By Country 16.6.1.1. USA 16.6.1.2. Canada 16.6.2. By Ingredients 16.6.3. By Dosage Form 16.6.4. By Route of Administration 16.6.5. By Indication 16.6.6. By Distribution Channel 16.7. Market Attractiveness Analysis 16.7.1. By Country 16.7.2. By Ingredients 16.7.3. By Dosage Form 16.7.4. By Route of Administration 16.7.5. By Indication 16.7.6. By Distribution Channel 16.8. Market Trends 16.9. Key Market Participants - Intensity Mapping 16.10. Drivers and Restraints - Impact Analysis 16.11. Country Level Analysis & Forecast 16.11.1. USA Market Analysis 16.11.1.1. Introduction 16.11.1.2. Market Analysis and Forecast by Market Taxonomy 16.11.1.2.1. By Ingredients 16.11.1.2.2. By Dosage Form 16.11.1.2.3. By Route of Administration 16.11.1.2.4. By Indication 16.11.1.2.5. By Distribution Channel 16.11.2. Canada Market Analysis 16.11.2.1. Introduction 16.11.2.2. Market Analysis and Forecast by Market Taxonomy 16.11.2.2.1. By Ingredients 16.11.2.2.2. By Dosage Form 16.11.2.2.3. By Route of Administration 16.11.2.2.4. By Indication 16.11.2.2.5. By Distribution Channel 17. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17.4. Introduction 17.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023 17.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034 17.6.1. By Country 17.6.1.1. Mexico 17.6.1.2. Brazil 17.6.1.3. Argentina 17.6.1.4. Rest of Latin America 17.6.2. By Ingredients 17.6.3. By Dosage Form 17.6.4. By Route of Administration 17.6.5. By Indication 17.6.6. By Distribution Channel 17.7. Market Attractiveness Analysis 17.7.1. By Country 17.7.2. By Ingredients 17.7.3. By Dosage Form 17.7.4. By Route of Administration 17.7.5. By Indication 17.7.6. By Distribution Channel 17.8. Market Trends 17.9. Key Market Participants - Intensity Mapping 17.10. Drivers and Restraints - Impact Analysis 17.11. Country Level Analysis & Forecast 17.11.1. Mexico Market Analysis 17.11.1.1. Introduction 17.11.1.2. Market Analysis and Forecast by Market Taxonomy 17.11.1.2.1. By Ingredients 17.11.1.2.2. By Dosage Form 17.11.1.2.3. By Route of Administration 17.11.1.2.4. By Indication 17.11.1.2.5. By Distribution Channel 17.11.2. Brazil Market Analysis 17.11.2.1. Introduction 17.11.2.2. Market Analysis and Forecast by Market Taxonomy 17.11.2.2.1. By Ingredients 17.11.2.2.2. By Dosage Form 17.11.2.2.3. By Route of Administration 17.11.2.2.4. By Indication 17.11.2.2.5. By Distribution Channel 17.11.3. Argentina Market Analysis 17.11.3.1. Introduction 17.11.3.2. Market Analysis and Forecast by Market Taxonomy 17.11.3.2.1. By Ingredients 17.11.3.2.2. By Dosage Form 17.11.3.2.3. By Route of Administration 17.11.3.2.4. By Indication 17.11.3.2.5. By Distribution Channel 18. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 18.4. Introduction 18.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023 18.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034 18.6.1. By Country 18.6.1.1. UK 18.6.1.2. Germany 18.6.1.3. Italy 18.6.1.4. France 18.6.1.5. Spain 18.6.1.6. Russia 18.6.1.7. BENELUX 18.6.1.8. Rest of Europe 18.6.2. By Ingredients 18.6.3. By Dosage Form 18.6.4. By Route of Administration 18.6.5. By Indication 18.6.6. By Distribution Channel 18.7. Market Attractiveness Analysis 18.7.1. By Country 18.7.2. By Ingredients 18.7.3. By Dosage Form 18.7.4. By Route of Administration 18.7.5. By Indication 18.7.6. By Distribution Channel 18.8. Market Trends 18.9. Key Market Participants - Intensity Mapping 18.10. Drivers and Restraints - Impact Analysis 18.11. Country Level Analysis & Forecast 18.11.1. UK Market Analysis 18.11.1.1. Introduction 18.11.1.2. Market Analysis and Forecast by Market Taxonomy 18.11.1.2.1. By Ingredients 18.11.1.2.2. By Dosage Form 18.11.1.2.3. By Route of Administration 18.11.1.2.4. By Indication 18.11.1.2.5. By Distribution Channel 18.11.2. Germany Market Analysis 18.11.2.1. Introduction 18.11.2.2. Market Analysis and Forecast by Market Taxonomy 18.11.2.2.1. By Ingredients 18.11.2.2.2. By Dosage Form 18.11.2.2.3. By Route of Administration 18.11.2.2.4. By Indication 18.11.2.2.5. By Distribution Channel 18.11.3. Italy Market Analysis 18.11.3.1. Introduction 18.11.3.2. Market Analysis and Forecast by Market Taxonomy 18.11.3.2.1. By Ingredients 18.11.3.2.2. By Dosage Form 18.11.3.2.3. By Route of Administration 18.11.3.2.4. By Indication 18.11.3.2.5. By Distribution Channel 18.11.4. France Market Analysis 18.11.4.1. Introduction 18.11.4.2. Market Analysis and Forecast by Market Taxonomy 18.11.4.2.1. By Ingredients 18.11.4.2.2. By Dosage Form 18.11.4.2.3. By Route of Administration 18.11.4.2.4. By Indication 18.11.4.2.5. By Distribution Channel 18.11.5. Spain Market Analysis 18.11.5.1. Introduction 18.11.5.2. Market Analysis and Forecast by Market Taxonomy 18.11.5.2.1. By Ingredients 18.11.5.2.2. By Dosage Form 18.11.5.2.3. By Route of Administration 18.11.5.2.4. By Indication 18.11.5.2.5. By Distribution Channel 18.11.6. Russia Market Analysis 18.11.6.1. Introduction 18.11.6.2. Market Analysis and Forecast by Market Taxonomy 18.11.6.2.1. By Ingredients 18.11.6.2.2. By Dosage Form 18.11.6.2.3. By Route of Administration 18.11.6.2.4. By Indication 18.11.6.2.5. By Distribution Channel 18.11.7. BENELUX Market Analysis 18.11.7.1. Introduction 18.11.7.2. Market Analysis and Forecast by Market Taxonomy 18.11.7.2.1. By Ingredients 18.11.7.2.2. By Dosage Form 18.11.7.2.3. By Route of Administration 18.11.7.2.4. By Indication 18.11.7.2.5. By Distribution Channel 19. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 19.4. Introduction 19.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023 19.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034 19.6.1. By Country 19.6.1.1. China 19.6.1.2. Japan 19.6.1.3. South Korea 19.6.2. By Ingredients 19.6.3. By Dosage Form 19.6.4. By Route of Administration 19.6.5. By Indication 19.6.6. By Distribution Channel 19.7. Market Attractiveness Analysis 19.7.1. By Country 19.7.2. By Ingredients 19.7.3. By Dosage Form 19.7.4. By Route of Administration 19.7.5. By Indication 19.7.6. By Distribution Channel 19.8. Market Trends 19.9. Key Market Participants - Intensity Mapping 19.10. Drivers and Restraints - Impact Analysis 19.11. Country Level Analysis & Forecast 19.11.1. China Market Analysis 19.11.1.1. Introduction 19.11.1.2. Market Analysis and Forecast by Market Taxonomy 19.11.1.2.1. By Ingredients 19.11.1.2.2. By Dosage Form 19.11.1.2.3. By Route of Administration 19.11.1.2.4. By Indication 19.11.1.2.5. By Distribution Channel 19.11.2. Japan Market Analysis 19.11.2.1. Introduction 19.11.2.2. Market Analysis and Forecast by Market Taxonomy 19.11.2.2.1. By Ingredients 19.11.2.2.2. By Dosage Form 19.11.2.2.3. By Route of Administration 19.11.2.2.4. By Indication 19.11.2.2.5. By Distribution Channel 19.11.3. South Korea Market Analysis 19.11.3.1. Introduction 19.11.3.2. Market Analysis and Forecast by Market Taxonomy 19.11.3.2.1. By Ingredients 19.11.3.2.2. By Dosage Form 19.11.3.2.3. By Route of Administration 19.11.3.2.4. By Indication 19.11.3.2.5. By Distribution Channel 20. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 20.4. Introduction 20.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023 20.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034 20.6.1. By Country 20.6.1.1. India 20.6.1.2. Indonesia 20.6.1.3. Malaysia 20.6.1.4. Thailand 20.6.1.5. Rest of South Asia 20.6.2. By Ingredients 20.6.3. By Dosage Form 20.6.4. By Route of Administration 20.6.5. By Indication 20.6.6. By Distribution Channel 20.7. Market Attractiveness Analysis 20.7.1. By Country 20.7.2. By Ingredients 20.7.3. By Dosage Form 20.7.4. By Route of Administration 20.7.5. By Indication 20.7.6. By Distribution Channel 20.8. Market Trends 20.9. Key Market Participants - Intensity Mapping 20.10. Drivers and Restraints - Impact Analysis 20.11. Country Level Analysis & Forecast 20.11.1. India Market Analysis 20.11.1.1. Introduction 20.11.1.2. Market Analysis and Forecast by Market Taxonomy 20.11.1.2.1. By Ingredients 20.11.1.2.2. By Dosage Form 20.11.1.2.3. By Route of Administration 20.11.1.2.4. By Indication 20.11.1.2.5. By Distribution Channel 20.11.2. Indonesia Market Analysis 20.11.2.1. Introduction 20.11.2.2. Market Analysis and Forecast by Market Taxonomy 20.11.2.2.1. By Ingredients 20.11.2.2.2. By Dosage Form 20.11.2.2.3. By Route of Administration 20.11.2.2.4. By Indication 20.11.2.2.5. By Distribution Channel 20.11.3. Malaysia Market Analysis 20.11.3.1. Introduction 20.11.3.2. Market Analysis and Forecast by Market Taxonomy 20.11.3.2.1. By Ingredients 20.11.3.2.2. By Dosage Form 20.11.3.2.3. By Route of Administration 20.11.3.2.4. By Indication 20.11.3.2.5. By Distribution Channel 20.11.4. Thailand Market Analysis 20.11.4.1. Introduction 20.11.4.2. Market Analysis and Forecast by Market Taxonomy 20.11.4.2.1. By Ingredients 20.11.4.2.2. By Dosage Form 20.11.4.2.3. By Route of Administration 20.11.4.2.4. By Indication 20.11.4.2.5. By Distribution Channel 21. Oceania Market 2019 to 2023 and Forecast 2024 to 2034 21.4. Introduction 21.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023 21.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034 21.6.1. By Country 21.6.1.1. Australia 21.6.1.2. New Zealand 21.6.2. By Ingredients 21.6.3. By Dosage Form 21.6.4. By Route of Administration 21.6.5. By Indication 21.6.6. By Distribution Channel 21.7. Market Attractiveness Analysis 21.7.1. By Country 21.7.2. By Ingredients 21.7.3. By Dosage Form 21.7.4. By Route of Administration 21.7.5. By Indication 21.7.6. By Distribution Channel 21.8. Market Trends 21.9. Key Market Participants - Intensity Mapping 21.10. Drivers and Restraints - Impact Analysis 21.11. Country Level Analysis & Forecast 21.11.1. Australia Market Analysis 21.11.1.1. Introduction 21.11.1.2. Market Analysis and Forecast by Market Taxonomy 21.11.1.2.1. By Ingredients 21.11.1.2.2. By Dosage Form 21.11.1.2.3. By Route of Administration 21.11.1.2.4. By Indication 21.11.1.2.5. By Distribution Channel 21.11.2. New Zealand Market Analysis 21.11.2.1. Introduction 21.11.2.2. Market Analysis and Forecast by Market Taxonomy 21.11.2.2.1. By Ingredients 21.11.2.2.2. By Dosage Form 21.11.2.2.3. By Route of Administration 21.11.2.2.4. By Indication 21.11.2.2.5. By Distribution Channel 22. Middle East and Africa (MEA) Market Analysis 2019 to 2023 and Forecast 2024 to 2034 22.4. Introduction 22.5. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2019 to 2023 22.6. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2024 to 2034 22.6.1. By Country 22.6.1.1. GCC Countries 22.6.1.2. Turkey 22.6.1.3. South Africa 22.6.1.4. North Africa 22.6.1.5. Rest of Middle East and Africa 22.6.2. By Ingredients 22.6.3. By Dosage Form 22.6.4. By Route of Administration 22.6.5. By Indication 22.6.6. By Distribution Channel 22.7. Market Attractiveness Analysis 22.7.1. By Country 22.7.2. By Ingredients 22.7.3. By Dosage Form 22.7.4. By Route of Administration 22.7.5. By Indication 22.7.6. By Distribution Channel 22.8. Market Trends 22.9. Key Market Participants - Intensity Mapping 22.10. Drivers and Restraints - Impact Analysis 22.11. Country Level Analysis & Forecast 22.11.1. GCC Countries Market Analysis 22.11.1.1. Introduction 22.11.1.2. Market Analysis and Forecast by Market Taxonomy 22.11.1.2.1. By Ingredients 22.11.1.2.2. By Dosage Form 22.11.1.2.3. By Route of Administration 22.11.1.2.4. By Indication 22.11.1.2.5. By Distribution Channel 22.11.2. Turkey Market Analysis 22.11.2.1. Introduction 22.11.2.2. Market Analysis and Forecast by Market Taxonomy 22.11.2.2.1. By Ingredients 22.11.2.2.2. By Dosage Form 22.11.2.2.3. By Route of Administration 22.11.2.2.4. By Indication 22.11.2.2.5. By Distribution Channel 22.11.3. South Africa Market Analysis 22.11.3.1. Introduction 22.11.3.2. Market Analysis and Forecast by Market Taxonomy 22.11.3.2.1. By Ingredients 22.11.3.2.2. By Dosage Form 22.11.3.2.3. By Route of Administration 22.11.3.2.4. By Indication 22.11.3.2.5. By Distribution Channel 22.11.4. North Africa Market Analysis 22.11.4.1. Introduction 22.11.4.2. Market Analysis and Forecast by Market Taxonomy 22.11.4.2.1. By Ingredients 22.11.4.2.2. By Dosage Form 22.11.4.2.3. By Route of Administration 22.11.4.2.4. By Indication 22.11.4.2.5. By Distribution Channel 23. Market Structure Analysis 23.4. Market Analysis by Tier of Companies 23.5. Market Share Analysis of Top Players (%) 23.6. Market Presence Analysis 23.6.1. By Regional Footprint of Players 23.6.2. Ingredients Footprint of Players 23.6.3. Channel Footprint of Players 24. Competition Analysis 24.4. Competition Dashboard 24.5. Competition Benchmarking 24.6. Competition Deep Dive 24.6.1. Pfizer Inc. 24.6.1.1. Overview 24.6.1.2. Ingredients & Services Portfolio 24.6.1.3. Key Financials 24.6.1.4. SWOT Analysis 24.6.1.5. Key Developments 24.6.1.6. Sales Footprint 24.6.1.7. Strategy Overview 24.6.1.7.1. Marketing Strategy 24.6.1.7.2. Ingredients Strategy 24.6.1.7.3. Channel Strategy 24.6.2. Novartis AG 24.6.3. Bausch & Lomb Incorporated. 24.6.4. Amway Corp. 24.6.5. Vitabiotics Ltd. 24.6.6. Alliance Pharma 24.6.7. The Nature's Bounty Co 24.6.8. ZeaVision, LLC. 24.6.9. Akorn Consumer Health 24.6.10. Eyescience Labs 24.6.11. Kemin Industries Inc. 24.6.12. NutraChamps 24.6.13. Nutrivein 24.6.14. Biosyntrx Inc 24.6.15. Nordic Naturals Inc. 24.6.16. Bristol-Myers Squibb Company 24.6.17. Healths Harmony LLC 24.6.18. NUSAPURE 24.6.19. Vitabiotics Ltd. 24.6.20. EyeScience 24.6.21. Butterflies Healthcare Ltd 24.6.22. Allergan plc 24.6.23. Herbalife Nutrition Ltd. 25. Assumptions and Acronyms Used 26. Research Methodology
Explore Healthcare Insights
View Reports
Eye Care Supplement Market
